Newsome R D, Ditzler T
Scott Medical Center, Scott AFB, Illinois 62225-5300.
J Nerv Ment Dis. 1993 Nov;181(11):689-94. doi: 10.1097/00005053-199311000-00007.
The reliability, validity, and heuristic value of Goldsmith and Green's (J. Nerv. Ment. Dis. 176:614-620, 1988) Denial Rating Scale (DRS) are examined in an inpatient treatment setting. This replication study includes 647 cases. The same strong relationship between clinical change and program completion as found by Goldsmith and Green is identified. An ordinal predictive validity for the DRS regarding program completion that was not found by Goldsmith and Green is also identified. Utility for improving patient treatment plans through DRS results is identified. The heuristic value of the DRS in helping an alcoholism counseling staff maintain treatment focus is discussed. It is recommended that treatment centers incorporate systematic assessment of denial over the course of treatment as a means to facilitate staff focus on the primacy of addiction.
在住院治疗环境中，对戈德史密斯和格林（《神经与精神疾病杂志》，第176卷，第614 - 620页，1988年）的否认评定量表（DRS）的信度、效度和启发价值进行了检验。这项重复研究包括647个病例。发现临床变化与项目完成之间存在与戈德史密斯和格林所发现的相同的强关联。还发现了戈德史密斯和格林未发现的DRS关于项目完成的序贯预测效度。确定了通过DRS结果改善患者治疗计划的效用。讨论了DRS在帮助酒精中毒咨询人员保持治疗重点方面的启发价值。建议治疗中心在治疗过程中纳入对否认的系统评估，以此作为促进工作人员关注成瘾首要问题的一种手段。
